Luca Liuzzi

• Contextualizing the growing focus on alternative payloads and formats as more non-traditional ADCs advance towards and through the clinic 
• Explaining how bispecific ADC manufacturing and conjugation presents unique challenges to process development and scale-up in a competitive environment
• Breaking down well-established hardware and expertise to shepherd clients through bispecific ADC production from cell-line establishment to labelled drug product

Speaker to be Confirmed, Mabplex